-
Dinaciclib–VHL Synthetic Lethality in CC-RCC
2026-08-20
Nelson and colleagues identify a synthetic-lethal relationship between Dinaciclib treatment and VHL deficiency in clear cell renal cell carcinoma. Their complementary cell-based and orthotopic patient-derived xenograft experiments indicate that Dinaciclib suppresses tumor growth, induces apoptosis, and affects both cancer stem and non-stem cell populations while showing greater protection in nonmalignant or VHL-restored cells that are not actively dividing.
-
Sodium Orthovanadate for Signaling Assays
2026-08-20
Sodium Orthovanadate helps preserve phosphorylation-dependent signals in adipocyte lysates, kinase assays, and enzyme workflows. This guide combines practical Na3VO4 handling with assay-specific controls inspired by research on PI3K/AKT/GLUT4 insulin signaling.
-
Gamma-linolenic acid: Workflow & Applications
2026-08-19
Gamma-linolenic acid (GLA) supports reproducible studies of LTB4-linked inflammation, lipid signaling, and cell death. This practical guide combines receptor, cell-based, and translational workflows with resistance-surveillance lessons from a psychiatric hospital study.
-
HDAC Inhibition Reverses EBV-Driven NPC Plasticity
2026-08-19
The reference study identifies an epigenetic mechanism through which EBV protein LMP1 drives dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma. It shows that HDAC inhibition can restore CEBPA expression and partially reverse this state in cellular and mouse xenograft models, supporting differentiation-based cancer therapy for selected solid tumors.
-
LNP Self-Replicating RNA Vaccine Storage: Key Evidence
2026-08-18
The reference study systematically examines how temperature, buffer composition, cryoprotection, and lyophilization affect lipid nanoparticle-formulated self-replicating RNA vaccines. Its central practical finding is that RNAse-free PBS containing 10% sucrose supported preservation of structure and in vivo potency at −20°C for 30 days, while lyophilization also retained bioactivity under the tested conditions.
-
Anti-Diabetic Drugs and Fracture Risk: Network Evidence
2026-08-18
This systematic review and network meta-analysis integrated randomized evidence on fracture outcomes across multiple anti-diabetic therapies in type 2 diabetes. Its main contribution is a drug-specific comparison showing statistically significant signals for trelagliptin, albiglutide, and voglibose, while most other agents—including ertugliflozin—remained statistically comparable with placebo.
-
IDO1 Inhibition Activates Tumor-Protective STAT3
2026-08-17
The reference study shows that apo-IDO1 inhibition can activate immune cells while simultaneously inducing an IL-6–JAK2/STAT3 survival program within tumor cells. Its single-cell and mechanistic analyses support combining IDO1-directed treatment with pathway-level inhibition to limit this adaptive, tumor-protective response.
-
Paclitaxel (Taxol) Workflows for Cancer Research
2026-08-17
Translate Paclitaxel’s microtubule-stabilizing activity into reproducible cell-cycle, cytotoxicity, and targeted nanomedicine assays. This guide connects free-drug experiments with the carrier-free PTX/GA@FA-HSA strategy reported for triple-negative breast cancer, while emphasizing dosing controls and troubleshooting.
-
Paroxetine Mesylate: Applied Research Workflows
2026-08-16
Paroxetine Mesylate supports controlled SERT, CYP, kinase, and translational oncology experiments rather than serving only as an SSRI reference compound. This guide presents assay-ready workflows, quantitative starting points, cross-domain interpretation, and troubleshooting strategies for reproducible research.
-
SMPD4, Ceramide, and Primary Cilia in Brain Development
2026-08-15
A 2024 Development study connects SMPD4-dependent ceramide production with neural progenitor survival, Purkinje cell development, cerebellar architecture, and primary cilium maintenance. By integrating a mouse model with SMPD4-deficient human induced pluripotent stem cell systems and a ceramide-rescue experiment, the work provides mechanistic insight into microcephaly and cerebellar hypoplasia.
-
Monomethyl auristatin E (MMAE) in ADC Research
2026-08-14
Monomethyl auristatin E (MMAE) is a highly potent tubulin polymerization inhibitor used as an antibody-drug conjugate payload. Its value in cancer therapy comes from coupling auristatin cytotoxicity to antibody-mediated delivery, while its standalone form is not tumor-selective.
-
Dihydroethidium in Ultrasound Redox Assays
2026-08-14
Dihydroethidium, also known as hydroethidine, offers a practical route to monitor superoxide-associated red fluorescence in living cells. This guide connects DHE assay design with ultrasound-activated nanoparticle therapy, clarifying what the signal can—and cannot—prove about ROS, peroxynitrite, and apoptosis.
-
Angiotensin (1-7): Assay Workflow & Uses
2026-08-13
Build more reproducible Mas-receptor experiments with Angiotensin (1-7), from renal epithelial signaling to peptide-degradation assays involving periodontal pathogens. This guide combines literature-backed concentrations and dosing ranges with practical controls for peptide handling, pathway validation, and troubleshooting.
-
Neuroligin 1 Proteolysis Sustains Social Memory
2026-08-13
Liu and colleagues show that social interaction triggers secretase-dependent cleavage of Neuroligin 1 in the ventral hippocampus, producing an intracellular fragment that supports synaptic remodeling and social memory maintenance. The study combines molecular, genetic, pharmacological, behavioral, and spine analyses to establish NLG1-CTD and its PDZ-binding domain as a mechanistic link between social experience and persistent hippocampal plasticity.
-
Tetraethylammonium Chloride in K+ Channel Workflows
2026-08-12
Tetraethylammonium chloride gives researchers a practical pore-blocking perturbation for connecting K+ channel activity with secretion, vascular tone, and ion conduction. This guide translates a landmark β-cell study into reproducible TEAC workflows, control strategies, and troubleshooting decisions.